Armata Pharmaceuticals (ARMP) Cash & Current Investments (2016 - 2026)
Quarterly results put Cash & Current Investments at $4.8 million for Q1 2026, down 59.33% from a year ago — trailing twelve months through Mar 2026 was $4.8 million (down 59.33% YoY), and the annual figure for FY2025 was $8.7 million, down 6.49%.
Armata Pharmaceuticals has reported Cash & Current Investments over the past 14 years, most recently at $4.8 million for Q1 2026.
- Cash & Current Investments reached $4.8 million in Q1 2026 per ARMP's latest filing, down from $8.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $46.4 million in Q1 2022 and bottomed at $4.3 million in Q2 2025.
- Median Cash & Current Investments over the past 5 years was $14.9 million (2022), compared with a mean of $19.6 million.
- The largest annual shift saw Cash & Current Investments surged 111.99% in 2024 before it crashed 83.72% in 2025.
- Over 5 years, Cash & Current Investments stood at $14.9 million in 2022, then decreased by 8.95% to $13.5 million in 2023, then plummeted by 31.29% to $9.3 million in 2024, then fell by 6.49% to $8.7 million in 2025, then crashed by 45.28% to $4.8 million in 2026.
- Business Quant data shows Cash & Current Investments for ARMP at $4.8 million in Q1 2026, $8.7 million in Q4 2025, and $14.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 8.69 Mn |
| Sep 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 11.69 Mn |
| Dec 31, 2024 | 9.29 Mn |
| Sep 30, 2024 | 17.14 Mn |
| Jun 30, 2024 | 26.41 Mn |
| Mar 31, 2024 | 37.86 Mn |
| Dec 31, 2023 | 13.52 Mn |
| Sep 30, 2023 | 23.96 Mn |
| Jun 30, 2023 | 12.46 Mn |
| Mar 31, 2023 | 25.11 Mn |
| Dec 31, 2022 | 14.85 Mn |
| Sep 30, 2022 | 25.38 Mn |
| Jun 30, 2022 | 36.98 Mn |
| Mar 31, 2022 | 46.41 Mn |
| Dec 31, 2021 | 10.29 Mn |
| Sep 30, 2021 | 12.08 Mn |
| Jun 30, 2021 | 17.54 Mn |
| Mar 31, 2021 | 22.46 Mn |
| Dec 31, 2020 | 9.65 Mn |
| Sep 30, 2020 | 15.89 Mn |
| Jun 30, 2020 | 19.79 Mn |
| Mar 31, 2020 | 24.21 Mn |
| Dec 31, 2019 | 6.03 Mn |
| Sep 30, 2019 | 8.69 Mn |
| Jun 30, 2019 | 13.19 Mn |
| Mar 31, 2019 | 6.16 Mn |
| Dec 31, 2018 | 9.66 Mn |
| Sep 30, 2018 | 13.39 Mn |
| Jun 30, 2018 | 15.42 Mn |
| Mar 31, 2018 | 8.21 Mn |
| Dec 31, 2017 | 5.13 Mn |
| Sep 30, 2017 | 7.73 Mn |
| Jun 30, 2017 | 8.96 Mn |
| Mar 31, 2017 | 2.20 Mn |
| Dec 31, 2016 | 5.13 Mn |
| Sep 30, 2016 | 3.97 Mn |
| Jun 30, 2016 | 7.14 Mn |